Back
Republic Services Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
70
RSG
Republic Services
Last Price:
$229.39
Seasonality Move:
9.65%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
$97.77
Seasonality Move:
6.73%
Buy
70
Republic Services (RSG)
is a Buy
Is Republic Services a Buy, Sell or Hold?
-
The current Republic Services [RSG] share price is $230.63. The Score for RSG is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RSG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RSG Stock Price Chart
What is Republic Services's stock price today?
-
The Republic Services share price today is $230.63The current trend is moderately bullish and RSG is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $99.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
RSG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4 | Buy |
Relative Strength Index (14 RSI): | 53.83 | Buy |
Chaikin Money Flow: | -577178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.12 - 234.7) | Buy |
Bollinger Bands (100): | (202.99 - 224.15) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -420668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.16 - 112.22) | Sell |
Bollinger Bands (100): | (109.63 - 127.19) | Sell |
RSG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 234.54 | Sell |
20-day SMA: | 230.94 | Sell |
50-day SMA: | 218.7 | Buy |
200-day SMA: | 205.72 | Buy |
8-day EMA: | 232.79 | Sell |
20-day EMA: | 230.1 | Buy |
50-day EMA: | 222.57 | Buy |
200-day EMA: | 205.96 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.49 | Sell |
20-day SMA: | 106.07 | Sell |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 126.52 | Sell |
8-day EMA: | 103.1 | Sell |
20-day EMA: | 106.21 | Sell |
50-day EMA: | 111.8 | Sell |
200-day EMA: | 120.79 | Sell |
Republic Services Earnings Growth & RSG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.61 per share, and an increase next year of $0.70 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Republic Services Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |